Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Health Ministry...

Health Ministry Proposes Schedule K Exemption, Boxed Warnings for Levonorgestrel Pills

Written By : Susmita Roy Published On 2026-09-17T19:30:52+05:30  |  Updated On 17 Sept 2026 7:30 PM IST
Amazon Only a Platform, Not Seller of Abortion Pills: Court Quashes Notice Against Directors
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The Union Health Ministry has proposed that packs and package inserts of levonorgestrel emergency contraceptive tablets (0.75 mg and 1.5 mg) carry boxed warnings stating that the pill is for emergency use, should not be used as regular contraception, may cause side effects if used frequently, is not an abortion pill, and does not protect against HIV or other sexually transmitted infections.

The Union Health Ministry has proposed adding levonorgestrel emergency contraceptive tablets in 0.75 mg and 1.5 mg strengths to Schedule K of the Drugs Rules, 1945. If finalized, the amendment would exempt these tablets from provisions requiring a sale license, subject to a condition that their packaging and package inserts carry boxed warnings on emergency use, frequent use, abortion, and protection against sexually transmitted infections.

The Central Government issued the draft after consulting the Drugs Technical Advisory Board, under Section 12(1) and Section 33(1) of the Drugs and Cosmetics Act, 1940.

Also Read:Emergency Contraceptive Pills May Soon Carry Stricter Warnings, Usage Restrictions Likely

Schedule K specifies which drugs receive exemptions from particular provisions of the Act and Rules, and the conditions attached to those exemptions.

Under Rule 123, an exemption applies only to the extent stated in the Schedule. Entry No. 15 currently lists specified chemical contraceptive tablets and exempts them from provisions requiring a sale licence. Its five listed compositions include combinations of levonorgestrel with ethinyloestradiol; the draft proposes adding levonorgestrel 0.75 mg/1.5 mg tablets as item (6).

The notice stated that the following draft of certain rules further to amend the Drugs Rules, 1945, which the Central Government proposes to make, in exercise of the powers conferred by subsection (1) of section 12 and subsection (1) of section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), after consultation with the Drugs Technical Advisory Board, is hereby published for information of all persons likely to be affected thereby, and notice is hereby given that the said draft rules shall be taken into consideration on or after the expiry of a period of thirty days from the date on which the copies of the Gazette of India containing these draft rules are made available to the public.

Also Read:Govt Proposes Stricter Controls on Syrups, Seeks Removal From Schedule K

"Objections and suggestions which may be received from any person within the period specified above will be considered by the Central Government," the notice added.

Comments may be addressed to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Government of India, U-6, Work Hall- C Wing, First Floor, Kartavya Bhawan-1, New Delhi, 110001, or emailed to
drugsdiv-mohfw@gov.in
.

In line with the above, the draft rules added

1. (i) These rules may be called the Drugs (...... Amendment) Rules, 2026.
(ii) These rules shall come into force from the date as specified by the Government at the time of final publication of the rules in the Official Gazette.
2. In the Drugs Rules, 1945, in Schedule K under entry No. 15 and entries relating thereto, the following entry shall be inserted, namely: ―

Class of Drugs

Extent and Conditions of Exemptions

(6)

After serial number 5, the following serial number and entry shall be inserted: -Levonorgestrel Tablets 0.75mg/1.5mg

After the words “the provisions of Chapter IV of the Act and the rules made thereunder which required them to be covered by a sale license” the following shall be inserted: -

(a) For Levonorgestrel Tablets 0.75mg/1.5mg, the following boxed warnings shall also be provided on packaging as well as in the package insert: Emergency contraceptive pill is only to be taken in emergency situations, not to be used as a regular contraceptive.

(b) Frequent use of the emergency contraceptive pill may lead to side effects. Visit the nearest health facility/Registered Medical Practitioner for regular contraception as soon as possible.

(c) It is not an abortion pill.

(d) It does not offer any protection against HIV or any sexually transmitted infections.

To view the official notice, click the link below:
/servlet/RDESController?command=rdm.ServletFileDisplay&app=rdes&partner=medical&type=20&sessionId=RDWEBFFSBVPEFZBWJCNG77SJ5MSKQC1HV1SAT&uid=
levonorgestrelcontraceptive pillschedule kUnion Health Ministryboxed warningpackage insertemergency use
Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Print Article
    Show Full Article
    Next Story

    Editorial

    Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit

    Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit

    Overcoming the Challenge of Maintaining Weight Reduction

    Overcoming the Challenge of Maintaining Weight Reduction

    Sympathetic Overactivity: The Driver of Hypertension in Young Indians

    Sympathetic Overactivity: The Driver of Hypertension in Young Indians

    Indias Medical Startups: From Innovation to Impact - Prof. (Dr) Yogendra Kumar Gupta

    India's Medical Startups: From Innovation to Impact - Prof. (Dr) Yogendra Kumar Gupta

    From Detection to Prevention: Making Prediabetes Screening and Early Intervention Routine. - Dr Mahesh Chavan

    From Detection to Prevention: Making Prediabetes Screening and Early Intervention Routine. - Dr...

    View All

    Journal Club Today

    Medical Bulletin 17/September/2026

    Medical Bulletin 17/September/2026

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok